The approval is supported by a combination of current clinical data and model-informed drug development techniques.

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...

Teva Pharmaceutical Industries Limited TEVA recently announced that the FDA has approved expanded use of its branded product, ...

Paris: The FDA has approved UZEDY, the first subcutaneous long-acting risperidone formulation utilizing SteadyTeq™ technology ...

Confused between a psychiatrist, psychologist, psychotherapist, or counselor? Experts explain who does what, when to seek ...

Psychiatric disorders affect over 20% of US adults, presenting complex challenges in diagnosis and treatment due to frequent ...

A 'game-changing' study has found that low levels of lithium may be a hidden cause of Alzheimer's disease, offering the hope ...

One of Gov. Gavin Newsom's marquee mental health programs may broaden its reach despite persistent questions about the number ...

Can light really help cure depression and insomnia Read ahead to know as our expert breaks down how bright light therapy mimics sunlight to boost mood energy and sleep ...

LeVine's creative life began with photography. As a young man, he captured moments with some of the world's most recognizable ...

Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for ...

Shawnee County leaders have agreed to a settlement with the family of a Topeka man who died while incarcerated. The family ...